John Trizzino
President bei NOVAVAX, INC.
Vermögen: 133 706 $ am 31.03.2024
Profil
Herr John J. Trizzino ist CFO, EVP, Chief Commercial & Business Officer bei Novavax, Inc. Herr Trizzino war zuvor als Chief Executive Officer & Director bei ImmunoVaccine, Inc. beschäftigt, als Vice President-Vaccine Franchise bei MedImmune LLC, als Vice President-Business Development bei ID Biomedical Corp. und als Vice President-Business Development bei Henry Schein, Inc. Er war auch im Vorstand des Tech Council of Maryland, Inc. Er erhielt seinen Bachelor-Abschluss von der Long Island University und einen MBA von der Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVAVAX, INC.
0,02% | 10.03.2024 | 27 972 ( 0,02% ) | 133 706 $ | 31.03.2024 |
Aktive Positionen von John Trizzino
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | President | 20.11.2023 |
Ehemalige bekannte Positionen von John Trizzino
| Unternehmen | Position | Ende |
|---|---|---|
| IMV INC. | Chief Executive Officer | 01.09.2013 |
| NOVAVAX, INC. | Corporate Officer/Principal | 06.09.2011 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01.01.2009 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2009 |
| HENRY SCHEIN, INC. | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von John Trizzino
| Long Island University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HENRY SCHEIN, INC. | Distribution Services |
| NOVAVAX, INC. | Health Technology |
| IMV INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
